poor ovarian response
Conditions
Interventions
Group 1:dydrogesterone
Sponsors
Lanzhou University Second Hospital
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Voluntarily participate, understand and sign the informed consent; 2. In line with IVF indications; 3. Aged between 20-45 years; 4. Patients diagnosed with POR according to the POR criteria established by The European Society for Human Reproduction and Embryology (ESHRE) in 2011.
Exclusion criteria
Exclusion criteria: 1. Contraindications to IVF treatment (previous history of arterial thromboembolic disease (such as stroke, cardiac infarction). Current or previous history of lower extremity deep vein thrombosis or pulmonary embolism. Current or past history of thromboembolism, active thrombophlebitis, or cerebrovascular disease. Severe liver, kidney, heart, lung dysfunction; history of malignant tumors, serious genetic diseases, etc.); 2. Patients diagnosed with PCOS according to Rotterdam criteria ; 3. Patients with normal ovarian function; 4. Chromosomal abnormalities in one parent; 5. Those who are allergic to dydrogesterone; 6. Patients who are allergic to medroxyprogesterone; 7. Participate in other drug clinical investigators within 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of oocytes retrieved; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of premature luteinizing hormone peaks;Human menopausal gonadotropin dosage;Human menopausal gonadotropin use time;The diameter of the follicle before ovulation;MII oocytes rate;Fertility rate;Top-qualified embryo rate;Viable embryo rate;Embryo implantation rate;Clinical pregnancy rate;Early abortion rate;Hormonal level; | — |
Countries
China
Contacts
Public ContactWang Fang
Lanzhou University Second Hospital
Outcome results
None listed